This page shows the latest Idis Managed Access news and features for those working in and with pharma, biotech and healthcare.
year at the IPA event, where its campaign for Idis swept the board. ... In addition to picking up Best of Show, Langland's campaign for Idis – which develops managed access programmes – also won Best use of Art Direction and a Gold Award for
I did this with Idis', an international campaign, was built around a series of documentary films designed to raise awareness of Idis' managed access programmes. ... And winning the Grand Global for our work for Idis is a real honour,” said Langland
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
The associated risks of providing access to drugs in development may mean life or death for both patients and companies. ... Tom Watson is head of US business development, Idis Managed Access, part of the Clinigen Group.
So enabling and maintaining access for patients indeed should be a strategic imperative from top management down. ... Companies should start thinking about Managed Access Programmes (MAPs) as early as possible in the transition from drug development to
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
No results were found
Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote...